title: Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues.
abstract: Glucagon like peptide (GLP-1) analogues are a relatively novel medication developed primarily for the treatment of type 2 diabetes since 2005. Although GLP-1 analogues have been shown to be more effective in the first few years of diagnosis in type 2 diabetes, we report a case of a patient with longstanding insulin-dependent diabetes started on a GLP-1 analogue, liraglutide, who now has controlled blood sugars without the need of insulin.
authors.affiliation: Diabetes and Endocrinology Department, Warwick Hospital, Warwick, UK.
authors.forename: Umar Y
authors.initials: UY
authors.lastname: Raja
authors.affiliation: Diabetes Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
authors.forename: Alison E
authors.initials: AE
authors.lastname: Eastaugh
authors.affiliation: Diabetes Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
authors.forename: Mohammed S
authors.initials: MS
authors.lastname: Younas
authors.affiliation: Diabetes Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
authors.forename: Wasim
authors.initials: W
authors.lastname: Hanif
keywords: GLP-1; GLP-1 analogues; Obesity; insulin-dependent diabetes; type 2 diabetes